ProQuest Investments IV, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ProQuest Investments IV, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ProQuest Investments IV, L.P.. ProQuest Investments IV, L.P. is 10% Owner in EAGLE PHARMACEUTICALS, INC. ($EGRX) and 10% Owner in Immune Design Corp. ($IMDZ) and 10% Owner in UroGen Pharma Ltd. ($URGN).
Latest Insider Trading Transactions of ProQuest Investments IV, L.P.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EGRX, IMDZ, URGN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 29 2017 | URGN | UroGen Pharma Ltd. | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 40.51 | 177,807 | 7,202,962 | 1,242,031 | 1.4 M to 1.2 M (-12.52 %) |
Nov 29 2017 | URGN | UroGen Pharma Ltd. | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 41.12 | 31,491 | 1,294,910 | 1,419,838 | 1.5 M to 1.4 M (-2.17 %) |
May 15 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Buy | J | 0.00 | 149,107 | 0 | 149,107 | 0 to 149.1 K |
May 15 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Buy | J | 0.00 | 149,107 | 0 | 172,381 | 23.3 K to 172.4 K (+640.66 %) |
May 15 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | J | 0.00 | 3,584,087 | 0 | 0 | 3.6 M to 0 (-100.00 %) |
Apr 03 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.13 | 61,420 | 5,105,845 | 3,584,087 | 3.6 M to 3.6 M (-1.68 %) |
Apr 03 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.02 | 23,689 | 1,966,661 | 3,645,507 | 3.7 M to 3.6 M (-0.65 %) |
Apr 03 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.00 | 6,223 | 516,509 | 3,669,196 | 3.7 M to 3.7 M (-0.17 %) |
Mar 29 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.01 | 1,600 | 132,816 | 23,274 | 24.9 K to 23.3 K (-6.43 %) |
Mar 29 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.00 | 1,300 | 107,900 | 24,874 | 26.2 K to 24.9 K (-4.97 %) |
Mar 29 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.01 | 500 | 41,505 | 6,777 | 7.3 K to 6.8 K (-6.87 %) |
Mar 29 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.00 | 400 | 33,200 | 7,277 | 7.7 K to 7.3 K (-5.21 %) |
Mar 29 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.01 | 58,755 | 4,877,253 | 3,675,419 | 3.7 M to 3.7 M (-1.57 %) |
Mar 29 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.02 | 6,182 | 513,230 | 3,734,174 | 3.7 M to 3.7 M (-0.17 %) |
Mar 29 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.00 | 37,731 | 3,131,673 | 3,740,356 | 3.8 M to 3.7 M (-1.00 %) |
Mar 23 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.01 | 700 | 58,107 | 3,778,087 | 3.8 M to 3.8 M (-0.02 %) |
Mar 23 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.10 | 500 | 41,550 | 3,778,787 | 3.8 M to 3.8 M (-0.01 %) |
Mar 20 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 82.10 | 51,883 | 4,259,594 | 3,779,287 | 3.8 M to 3.8 M (-1.35 %) |
Mar 20 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 82.01 | 38,997 | 3,198,144 | 3,831,170 | 3.9 M to 3.8 M (-1.01 %) |
Mar 20 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 82.08 | 9,120 | 748,570 | 3,870,167 | 3.9 M to 3.9 M (-0.24 %) |
Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 85.16 | 65,114 | 5,545,108 | 3,879,287 | 3.9 M to 3.9 M (-1.65 %) |
Nov 14 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 85.00 | 15,551 | 1,321,835 | 3,944,401 | 4 M to 3.9 M (-0.39 %) |
Nov 14 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 85.00 | 1,300 | 110,500 | 26,174 | 27.5 K to 26.2 K (-4.73 %) |
Nov 14 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 85.00 | 300 | 25,500 | 7,677 | 8 K to 7.7 K (-3.76 %) |
Nov 14 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 87.05 | 1,700 | 147,985 | 3,959,952 | 4 M to 4 M (-0.04 %) |
Nov 14 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 86.06 | 100 | 8,606 | 3,961,652 | 4 M to 4 M (0.00 %) |
Nov 14 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 86.00 | 167 | 14,362 | 3,961,752 | 4 M to 4 M (0.00 %) |
Nov 14 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 85.10 | 15,368 | 1,307,817 | 3,961,919 | 4 M to 4 M (-0.39 %) |
Nov 09 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 80.09 | 102,919 | 8,242,783 | 3,977,287 | 4.1 M to 4 M (-2.52 %) |
Nov 09 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 79.24 | 19,581 | 1,551,598 | 4,080,206 | 4.1 M to 4.1 M (-0.48 %) |
Nov 09 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 78.23 | 4,200 | 328,566 | 4,099,787 | 4.1 M to 4.1 M (-0.10 %) |
Nov 09 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 77.13 | 9,030 | 696,484 | 4,103,987 | 4.1 M to 4.1 M (-0.22 %) |
Nov 09 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 76.49 | 11,690 | 894,168 | 4,113,017 | 4.1 M to 4.1 M (-0.28 %) |
Nov 09 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 75.70 | 1,380 | 104,466 | 4,124,707 | 4.1 M to 4.1 M (-0.03 %) |
Nov 09 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 75.39 | 5,030 | 379,212 | 4,126,087 | 4.1 M to 4.1 M (-0.12 %) |
Nov 04 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 75.00 | 46,170 | 3,462,750 | 4,181,446 | 4.2 M to 4.2 M (-1.09 %) |
Nov 04 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 70.00 | 2,100 | 147,000 | 27,474 | 29.6 K to 27.5 K (-7.10 %) |
Nov 04 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 70.00 | 800 | 56,000 | 7,977 | 8.8 K to 8 K (-9.11 %) |
Nov 04 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 70.41 | 50,329 | 3,543,665 | 4,177,287 | 4.2 M to 4.2 M (-1.19 %) |
Nov 04 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 70.00 | 146,371 | 10,245,970 | 4,227,616 | 4.4 M to 4.2 M (-3.35 %) |
Oct 04 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 70.06 | 22,100 | 1,548,326 | 4,373,987 | 4.4 M to 4.4 M (-0.50 %) |
Sep 30 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 70.04 | 77,900 | 5,456,116 | 4,396,087 | 4.5 M to 4.4 M (-1.74 %) |
Sep 23 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 66.17 | 654 | 43,275 | 29,574 | 30.2 K to 29.6 K (-2.16 %) |
Sep 23 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 66.17 | 194 | 12,837 | 8,777 | 9 K to 8.8 K (-2.16 %) |
Sep 23 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 67.24 | 1,798 | 120,898 | 4,473,987 | 4.5 M to 4.5 M (-0.04 %) |
Sep 23 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 66.15 | 97,149 | 6,426,406 | 4,475,785 | 4.6 M to 4.5 M (-2.12 %) |
Sep 08 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.33 | 224 | 13,962 | 30,228 | 30.5 K to 30.2 K (-0.74 %) |
Sep 08 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.33 | 66 | 4,114 | 8,971 | 9 K to 9 K (-0.73 %) |
Sep 08 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.33 | 33,796 | 2,106,505 | 4,572,934 | 4.6 M to 4.6 M (-0.73 %) |
Sep 08 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.26 | 75 | 4,670 | 30,452 | 30.5 K to 30.5 K (-0.25 %) |
Sep 08 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.26 | 22 | 1,370 | 9,037 | 9.1 K to 9 K (-0.24 %) |
Sep 08 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.26 | 11,345 | 706,340 | 4,606,730 | 4.6 M to 4.6 M (-0.25 %) |
Sep 08 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.83 | 166 | 10,430 | 30,527 | 30.7 K to 30.5 K (-0.54 %) |
Sep 08 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.83 | 49 | 3,079 | 9,059 | 9.1 K to 9.1 K (-0.54 %) |
Sep 08 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 63.25 | 12,224 | 773,168 | 4,618,075 | 4.6 M to 4.6 M (-0.26 %) |
Sep 08 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.45 | 12,958 | 809,227 | 4,630,299 | 4.6 M to 4.6 M (-0.28 %) |
Aug 25 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.78 | 76 | 4,771 | 30,693 | 30.8 K to 30.7 K (-0.25 %) |
Aug 25 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.78 | 23 | 1,444 | 9,108 | 9.1 K to 9.1 K (-0.25 %) |
Aug 25 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.78 | 11,506 | 722,347 | 4,643,257 | 4.7 M to 4.6 M (-0.25 %) |
Aug 25 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 63.12 | 113 | 7,133 | 30,769 | 30.9 K to 30.8 K (-0.37 %) |
Aug 25 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 63.12 | 34 | 2,146 | 9,131 | 9.2 K to 9.1 K (-0.37 %) |
Aug 25 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 63.14 | 17,118 | 1,080,831 | 4,654,763 | 4.7 M to 4.7 M (-0.37 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 61.00 | 96 | 5,856 | 30,882 | 31 K to 30.9 K (-0.31 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 61.00 | 29 | 1,769 | 5,387 | 5.4 K to 5.4 K (-0.54 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 61.19 | 9,848 | 602,599 | 4,671,779 | 4.7 M to 4.7 M (-0.21 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 60.85 | 4,723 | 287,395 | 4,681,627 | 4.7 M to 4.7 M (-0.10 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 60.78 | 394 | 23,947 | 30,978 | 31.4 K to 31 K (-1.26 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 60.78 | 117 | 7,111 | 5,416 | 5.5 K to 5.4 K (-2.11 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 62.21 | 31,599 | 1,965,774 | 4,686,350 | 4.7 M to 4.7 M (-0.67 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 61.65 | 11,770 | 725,621 | 4,717,949 | 4.7 M to 4.7 M (-0.25 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 60.66 | 16,270 | 986,938 | 4,729,719 | 4.7 M to 4.7 M (-0.34 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 60.70 | 163 | 9,894 | 31,372 | 31.5 K to 31.4 K (-0.52 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 60.70 | 49 | 2,974 | 5,533 | 5.6 K to 5.5 K (-0.88 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 61.31 | 8,070 | 494,772 | 4,745,989 | 4.8 M to 4.7 M (-0.17 %) |
Aug 17 2016 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 60.51 | 16,667 | 1,008,520 | 4,754,059 | 4.8 M to 4.8 M (-0.35 %) |
May 13 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 21.50 | 155,000 | 3,332,500 | 1,983,858 | 2.1 M to 2 M (-7.25 %) |
May 13 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 22.26 | 22,607 | 503,232 | 2,138,858 | 2.2 M to 2.1 M (-1.05 %) |
Apr 24 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.64 | 25,000 | 666,000 | 2,161,465 | 2.2 M to 2.2 M (-1.14 %) |
Apr 24 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.35 | 22,643 | 619,286 | 2,186,465 | 2.2 M to 2.2 M (-1.02 %) |
Apr 24 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.64 | 10,000 | 266,400 | 2,209,108 | 2.2 M to 2.2 M (-0.45 %) |
Apr 24 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.56 | 25,249 | 670,613 | 2,219,108 | 2.2 M to 2.2 M (-1.12 %) |
Apr 21 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.35 | 14,167 | 373,300 | 2,244,357 | 2.3 M to 2.2 M (-0.63 %) |
Apr 21 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.44 | 12,792 | 338,220 | 2,258,524 | 2.3 M to 2.3 M (-0.56 %) |
Apr 21 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.67 | 18,861 | 503,023 | 2,271,316 | 2.3 M to 2.3 M (-0.82 %) |
Apr 16 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.75 | 100 | 2,675 | 2,290,177 | 2.3 M to 2.3 M (0.00 %) |
Apr 16 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 29.17 | 100 | 2,917 | 2,290,277 | 2.3 M to 2.3 M (0.00 %) |
Apr 16 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 28.57 | 39,900 | 1,139,943 | 2,290,377 | 2.3 M to 2.3 M (-1.71 %) |
Apr 16 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.26 | 13,814 | 376,570 | 2,330,277 | 2.3 M to 2.3 M (-0.59 %) |
Apr 08 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.55 | 3,600 | 95,580 | 2,344,091 | 2.3 M to 2.3 M (-0.15 %) |
Apr 08 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.88 | 3,895 | 104,698 | 2,347,691 | 2.4 M to 2.3 M (-0.17 %) |
Apr 02 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.07 | 8,035 | 217,507 | 2,351,586 | 2.4 M to 2.4 M (-0.34 %) |
Apr 02 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.55 | 39,819 | 1,057,194 | 2,359,621 | 2.4 M to 2.4 M (-1.66 %) |
Apr 02 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.51 | 14,600 | 372,446 | 2,399,440 | 2.4 M to 2.4 M (-0.60 %) |
Mar 26 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.56 | 4,956 | 136,587 | 2,414,040 | 2.4 M to 2.4 M (-0.20 %) |
Mar 26 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.67 | 13,200 | 365,244 | 2,418,996 | 2.4 M to 2.4 M (-0.54 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.78 | 5,000 | 138,900 | 2,432,196 | 2.4 M to 2.4 M (-0.21 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 28.15 | 84 | 2,365 | 2,437,196 | 2.4 M to 2.4 M (0.00 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 28.13 | 400 | 11,252 | 2,437,280 | 2.4 M to 2.4 M (-0.02 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 28.04 | 200 | 5,608 | 2,437,680 | 2.4 M to 2.4 M (-0.01 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.19 | 8,780 | 238,749 | 2,437,880 | 2.4 M to 2.4 M (-0.36 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 28.07 | 200 | 5,614 | 2,446,660 | 2.4 M to 2.4 M (-0.01 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.55 | 29,800 | 820,990 | 2,446,860 | 2.5 M to 2.4 M (-1.20 %) |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.02 | 100 | 2,702 | 2,476,660 | 2.5 M to 2.5 M (0.00 %) |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.99 | 500 | 13,495 | 2,476,760 | 2.5 M to 2.5 M (-0.02 %) |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.04 | 100 | 2,704 | 2,477,260 | 2.5 M to 2.5 M (0.00 %) |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.56 | 19,300 | 512,608 | 2,477,360 | 2.5 M to 2.5 M (-0.77 %) |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.94 | 20,000 | 518,800 | 2,496,660 | 2.5 M to 2.5 M (-0.79 %) |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.43 | 10,309 | 262,158 | 2,516,660 | 2.5 M to 2.5 M (-0.41 %) |
Mar 12 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 24.94 | 94,199 | 2,349,323 | 2,526,969 | 2.6 M to 2.5 M (-3.59 %) |
Mar 12 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.02 | 29,000 | 725,580 | 2,621,168 | 2.7 M to 2.6 M (-1.09 %) |
Mar 12 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 24.65 | 6,143 | 151,425 | 2,650,168 | 2.7 M to 2.7 M (-0.23 %) |
Mar 09 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.61 | 32,300 | 827,203 | 2,656,311 | 2.7 M to 2.7 M (-1.20 %) |
Mar 09 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.02 | 100 | 2,502 | 2,688,611 | 2.7 M to 2.7 M (0.00 %) |
Mar 09 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.00 | 1,046 | 26,150 | 2,688,711 | 2.7 M to 2.7 M (-0.04 %) |
Mar 09 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 24.65 | 6,000 | 147,900 | 2,689,757 | 2.7 M to 2.7 M (-0.22 %) |
Page: 1